MarketCap
Facebook
X
Telegram
Happiness Biotech Group Limited EV - Enterprise Value | HAPP
Annual EV - Enterprise Value Happiness Biotech Group Limited
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.44 M | 6.3 M | 2.22 M | 19.1 M | 9.18 M | -21.5 M | -4.3 M | 82 M | -40.1 K | 18.2 M | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 82 M | -21.5 M | 10.5 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amneal Pharmaceuticals
AMRX
|
4.03 B | $ 21.07 | 3.39 % | $ 6.6 B |  USA |
 |
AnaptysBio
ANAB
|
1.46 B | $ 48.78 | 0.1 % | $ 1.41 B | USA |
 |
Aclaris Therapeutics
ACRS
|
422 M | $ 3.77 | 0.4 % | $ 462 M | USA |
 |
AC Immune SA
ACIU
|
370 M | $ 2.3 | -4.96 % | $ 232 M |  Schweiz |
 |
Five Prime Therapeutics, Inc.
FPRX
|
880 M | - | - | $ 1.77 B | USA |
 |
Adagene
ADAG
|
176 M | $ 2.49 | 3.32 % | $ 147 M |  China |
 |
ADMA Biologics
ADMA
|
3.84 B | $ 11.05 | 3.46 % | $ 2.63 B | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
2.7 B | $ 26.3 | 3.1 % | $ 3.99 B | USA |
 |
Agenus
AGEN
|
94.8 M | $ 6.19 | -2.21 % | $ 184 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
1.65 B | $ 36.67 | -0.91 % | $ 2.13 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
847 M | $ 4.2 | 0.12 % | $ 805 M |  Canada |
 |
ADC Therapeutics SA
ADCT
|
386 M | $ 1.51 | 4.51 % | $ 192 M | Schweiz |
 |
AbbVie
ABBV
|
394 B | $ 286.99 | 0.47 % | $ 508 B | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
3.81 B | $ 19.75 | 0.08 % | $ 3.33 B | USA |
 |
Artelo Biosciences
ARTL
|
3.73 M | $ 2.32 | -10.98 % | $ 439 K | USA |
 |
Biofrontera AG
BFRA
|
744 M | - | -8.24 % | $ 105 M |  Germany |
 |
Aquestive Therapeutics
AQST
|
540 M | $ 3.98 | -0.63 % | $ 426 M | USA |
 |
Armata Pharmaceuticals
ARMP
|
599 M | $ 3.46 | -4.95 % | $ 125 M | USA |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
168 B | - | -6.97 % | $ 657 M | USA |
 |
Atara Biotherapeutics
ATRA
|
124 M | $ 8.31 | -3.26 % | $ 104 M | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
15.4 B | - | 1.68 % | $ 4.65 B | China |
 |
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.54 | -0.32 % | $ 410 M |  Britain |
 |
Bicycle Therapeutics plc
BCYC
|
-169 M | $ 3.66 | 3.1 % | $ 254 M | Britain |
 |
BeyondSpring
BYSI
|
111 M | $ 0.47 | 9.77 % | $ 19.3 M | USA |
 |
Flexion Therapeutics, Inc.
FLXN
|
1.49 B | - | - | $ 459 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
1.86 B | $ 72.06 | -0.76 % | $ 1.45 B | USA |
 |
Ardelyx
ARDX
|
1.89 B | $ 3.01 | -2.31 % | $ 726 M | USA |
 |
argenx SE
ARGX
|
40.2 B | $ 866.15 | -0.86 % | $ 53.1 B |  Niderland |
 |
Arvinas
ARVN
|
1.01 B | $ 7.28 | -0.34 % | $ 516 M | USA |
 |
Axsome Therapeutics
AXSM
|
8.95 B | $ 143.88 | -0.8 % | $ 7.16 B | USA |
 |
Heat Biologics, Inc.
HTBX
|
4.26 B | - | -5.76 % | $ 99.8 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
20.2 B | - | 0.11 % | $ 419 M | USA |
 |
BioNTech SE
BNTX
|
17.1 B | $ 86.9 | -1.38 % | $ 21 B | Germany |
 |
Alterity Therapeutics Limited
ATHE
|
29.4 B | $ 2.1 | 0.48 % | $ 13.4 B |  Australia |
 |
Shineco, Inc.
TYHT
|
22.9 B | - | -3.90 % | $ 97.2 M | China |
 |
Actinium Pharmaceuticals
ATNM
|
26.8 M | $ 1.41 | -7.24 % | $ 44 M | USA |
 |
Millendo Therapeutics, Inc.
MLND
|
31.7 B | - | -5.36 % | $ 20.2 M | USA |
 |
Aytu BioScience
AYTU
|
1.16 M | $ 1.93 | 1.58 % | $ 23.8 M | USA |
 |
Codexis
CDXS
|
157 M | $ 1.29 | 0.39 % | $ 112 M | USA |
 |
Intec Pharma Ltd
NTEC
|
2.88 B | - | -12.45 % | $ 17.7 M |  Israel |
 |
Genmab A/S
GMAB
|
1.41 B | $ 44.64 | 1.94 % | $ 2.89 B |  Danmark |
 |
GeoVax Labs
GOVX
|
658 K | $ 0.19 | -7.18 % | $ 182 K | USA |
 |
Cellectar Biosciences
CLRB
|
-651 K | $ 1.23 | 0.82 % | $ 3.21 M | USA |
 |
Galectin Therapeutics
GALT
|
306 M | $ 3.19 | -0.31 % | $ 204 M | USA |
 |
GT Biopharma
GTBP
|
-2.9 M | $ 5.17 | -5.31 % | $ 28.5 M | USA |
 |
Progenity, Inc.
PROG
|
225 M | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
-3.98 M | $ 1.81 | 0.22 % | $ 1.69 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
32.8 B | - | 1.52 % | $ 136 M | USA |
 |
Cue Biopharma
CUE
|
18 M | $ 18.45 | -1.1 % | $ 1.75 B | USA |
 |
Seneca Biopharma, Inc.
SNCA
|
2.82 B | - | -1.19 % | $ 28.7 M | USA |